Cargando…

Paraneoplastic Myeloneuropathies: Clinical, Oncologic, and Serologic Accompaniments

OBJECTIVE: To test the hypothesis that myeloneuropathy is a presenting phenotype of paraneoplastic neurologic syndromes we retrospectively reviewed clinical, radiologic, and serologic features of 32 patients with concomitant paraneoplastic spinal cord and peripheral nervous system involvement. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shah, Shailee, Vazquez Do Campo, Rocio, Kumar, Neeraj, McKeon, Andrew, Flanagan, Eoin P., Klein, Christopher, Pittock, Sean J., Dubey, Divyanshu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7905784/ https://www.ncbi.nlm.nih.gov/pubmed/33208548 http://dx.doi.org/10.1212/WNL.0000000000011218

Ejemplares similares

Population-Based Epidemiology Study of Paraneoplastic Neurologic Syndromes
por: Shah, Shailee, et al.
Publicado: (2021)

Phenotypic presentations of paraneoplastic neuropathies associated with MAP1B-IgG
por: Jitprapaikulsan, Jiraporn, et al.
Publicado: (2020)

Clinical spectrum of high-titre GAD65 antibodies
por: Budhram, Adrian, et al.
Publicado: (2021)

Paraneoplastic neuronal intermediate filament autoimmunity
por: Basal, Eati, et al.
Publicado: (2018)

CDR2 and CDR2L line blot performance in PCA-1/anti-Yo paraneoplastic autoimmunity
por: Vorasoot, Nisa, et al.
Publicado: (2023)

Contactin-1 autoimmunity: Serologic, neurologic, and pathologic correlates
por: Dubey, Divyanshu, et al.
Publicado: (2020)

Approach to a case of myeloneuropathy
por: Garg, Ravindra Kumar, et al.
Publicado: (2016)

Identification of SKOR2 IgG as a novel biomarker of paraneoplastic neurologic syndrome
por: Rezk, Mohamed, et al.
Publicado: (2023)

B-cell–targeted therapies in relapsing forms of MS
por: Dubey, Divyanshu, et al.
Publicado: (2017)

Elevated LGI1‐IgG CSF index predicts worse neurological outcome
por: Gadoth, Avi, et al.
Publicado: (2018)

Autoimmune Encephalitis Criteria in Clinical Practice
por: Orozco, Emma, et al.
Publicado: (2023)

Neuronal intermediate filament IgGs in CSF: Autoimmune Axonopathy Biomarkers
por: McKeon, Andrew, et al.
Publicado: (2020)

Brain dysfunction and thyroid antibodies: autoimmune diagnosis and misdiagnosis
por: Valencia-Sanchez, Cristina, et al.
Publicado: (2021)

Stiff person spectrum disorder diagnosis, misdiagnosis, and suggested diagnostic criteria
por: Chia, Nicholas H., et al.
Publicado: (2023)

Phosphodiesterase 10A IgG: A novel biomarker of paraneoplastic neurologic autoimmunity
por: Zekeridou, Anastasia, et al.
Publicado: (2019)

Progressive myeloneuropathy with symptomatic anaemia
por: Rohm, Charlene L, et al.
Publicado: (2019)

Paraneoplastic autoimmunity and small‐cell lung cancer: Neurological and serological accompaniments
por: Zekeridou, Anastasia, et al.
Publicado: (2019)

Paraneoplastic Neurologic Disorders
por: Gilligan, Michael, et al.
Publicado: (2023)

Chlorpyrifos toxicity causing delayed myeloneuropathy
por: Ostwal, Piyush, et al.
Publicado: (2013)

Copper Deficiency Myeloneuropathy in Autoimmune Disease
por: Grossman, Jonathan T, et al.
Publicado: (2021)

Idiopathic Copper Deficiency Induced Myeloneuropathy
por: AL-Tabbaa, Mohammad Mousbah, et al.
Publicado: (2021)

Utility of Protein Microarrays for Detection of Classified and Novel Antibodies in Autoimmune Neurologic Disease
por: McKeon, Andrew, et al.
Publicado: (2023)

Acute myeloneuropathy: An uncommon presentation of Sjögren's syndrome
por: Verma, Rajesh, et al.
Publicado: (2013)

IgLON5 antibody: Neurological accompaniments and outcomes in 20 patients
por: Honorat, Josephe A., et al.
Publicado: (2017)

Paraneoplastic neurological syndromes: clinical presentations and management
por: Devine, Michelle F., et al.
Publicado: (2021)

Eculizumab for the treatment of glycine receptor antibody associated stiff-person syndrome
por: McCombe, Jennifer A., et al.
Publicado: (2023)

Updated Diagnostic Criteria for Paraneoplastic Neurologic Syndromes
por: Graus, Francesc, et al.
Publicado: (2021)

Autoimmune gait disturbance accompanying adaptor protein-3B2-IgG
por: Honorat, Josephe A., et al.
Publicado: (2019)

Neurological Manifestations of Myeloneuropathy in Patients with Nitrous Oxide Intoxication
por: Kang, Sung Woo, et al.
Publicado: (2019)

Myeloneuropathy in the Setting of Hypocupremia: An Overview of Copper-Related Pathophysiology
por: Marotta, Dario A, et al.
Publicado: (2021)

Nitrous oxide-induced myeloneuropathy: a case series
por: Mair, Devan, et al.
Publicado: (2023)

Magnetic resonance imaging-negative myeloneuropathy and bilateral facial paresis unfurling systemic lupus erythematosus
por: Ghosh, Ritwik, et al.
Publicado: (2022)

Copper deficiency, a new triad: anemia, leucopenia, and myeloneuropathy
por: Wazir, Shoaib M., et al.
Publicado: (2017)

Nitrous Oxide-induced B12 Deficiency Presenting With Myeloneuropathy
por: Edigin, Ehizogie, et al.
Publicado: (2019)

Nitrous oxide-induced myeloneuropathy: an emerging public health issue
por: McCormick, John P., et al.
Publicado: (2022)

βIV-Spectrin Autoantibodies in 2 Individuals With Neuropathy of Possible Paraneoplastic Origin: A Case Series
por: Bartley, Christopher M., et al.
Publicado: (2022)

LGI1 antibody encephalitis: acute treatment comparisons and outcome
por: Rodriguez, Andrew, et al.
Publicado: (2022)

Copper deficiency myeloneuropathy in a patient with haemachromatosis: a case report
por: Scurr, Cosmo, et al.
Publicado: (2009)

Neurochondrin neurological autoimmunity
por: Shelly, Shahar, et al.
Publicado: (2019)

Organophosphorus-Induced Toxic Myeloneuropathy: Series of Three Adolescent Patients with Short Review
por: Nayak, Priyabrata, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_29c9msudjn9i1frkccpvuuq98r